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A Genomewide Overexpression Screen Identifies Genes Involved in
the Phosphatidylinositol 3-Kinase Pathway in the Human Protozoan
Parasite Entamoeba histolytica
Amrita B. Koushik,a,c Brenda H. Welter,b,c Michelle L. Rock,b,c Lesly A. Temesvarib,c
Department of Genetics and Biochemistry,a Department of Biological Sciences,b and Eukaryotic Pathogens Innovation Center (EPIC),c Clemson University, Clemson, South
Carolina, USA
Entamoeba histolytica is a protozoan parasite that causes amoebic dysentery and liver abscess. E. histolytica relies on motility,
phagocytosis, host cell adhesion, and proteolysis of extracellular matrix for virulence. In eukaryotic cells, these processes are
mediated in part by phosphatidylinositol 3-kinase (PI3K) signaling. Thus, PI3K may be critical for virulence. We utilized a func-
tional genomics approach to identify genes whose products may operate in the PI3K pathway in E. histolytica. We treated a pop-
ulation of trophozoites that were overexpressing genes from a cDNA library with a near-lethal dose of the PI3K inhibitor wort-
mannin. This screen was based on the rationale that survivors would be overexpressing gene products that directly or indirectly
function in the PI3K pathway. We sequenced the overexpressed genes in survivors and identified a cDNA encoding a Rap
GTPase, a protein previously shown to participate in the PI3K pathway. This supports the validity of our approach. Genes en-
coding a coactosin-like protein, EhCoactosin, and a serine-rich E. histolytica protein (SREHP) were also identified. Cells overex-
pressing EhCoactosin or SREHP were also less sensitive to a second PI3K inhibitor, LY294002. This corroborates the link be-
tween these proteins and PI3K. Finally, a mutant cell line with an increased level of phosphatidylinositol (3,4,5)-triphosphate,
the product of PI3K activity, exhibited increased expression of SREHP and EhCoactosin. This further supports the functional
connection between these proteins and PI3K in E. histolytica. To our knowledge, this is the first forward-genetics screen adapted
to reveal genes participating in a signal transduction pathway in this pathogen.
Entamoeba histolytica is an enteric protozoan parasite thatcauses amoebiasis and amoebic liver abscess in humans (1). It
is prevalent in developing countries that cannot prevent its fecal-
oral spread. E. histolytica enters the human host upon ingestion of
water or food contaminated with environmentally stable cysts.
After passing through the stomach, excystation leads to the release
of trophozoites, which migrate to the bowel lumen for coloniza-
tion. In 10% of infected individuals, infection can progress from a
noninvasive stage to an invasive stage (2), during which the para-
site binds to and destroys colonic epithelium. From here, the par-
asites enter the circulatory system and translocate to other organs.
The most common site of extraintestinal infection is the liver,
characterized by the formation of amebic liver abscess (ALA).
E. histolytica relies on cell motility, phagocytosis, proteolysis of
host extracellular matrix, and host cell adhesion for virulence (3).
In other eukaryotic cells, these processes are mediated in part by
phosphatidylinositol 3-kinase (PI3K) signaling (4). PI3Ks phos-
phorylate phosphatidylinositol (PI) and its derivatives to generate
signaling lipids such as phosphatidylinositol 3-phosphate (PI3P),
phosphatidylinositol 3,4-bisphosphate [PI(3,4)P2], phosphatidyl-
inositol 3,5-bisphosphate [PI(3,5)P2], and phosphatidylinositol
3,4,5-trisphosphate [PI(3,4,5)P3] (reviewed in reference 5). These
lipids propagate a signal by interacting with proteins harboring
specific domains, such as the FYVE finger domains, which bind
PI3P, and pleckstrin homology (PH) domains, which bind
PI(3,4,5)P3 and PI(3,4)P2 (reviewed in reference 6). The activity
of PI3K can be countered by the action of phosphatases, such as
phosphatase and tensin homolog (PTEN), which dephosphory-
late phosphoinositides (reviewed in reference 7).
In E. histolytica, the products of PI3Ks have been studied using
glutathione S-transferase (GST)- and green fluorescent protein
(GFP)-tagged versions of FYVE and PH domains (8–10). These
studies have shown that PI3P localizes to E. histolytica phago-
somes (8, 9) and PI(3,4,5)P3 localizes to both pseudopods and
phagosomes (10). Studies using small-molecule inhibitors of
PI3K, such as LY294002 and wortmannin, have also been carried
out. Treatment of E. histolytica trophozoites with wortmannin
inhibits directional cell polarization (11), motility, actin cytoskel-
etal rearrangements, proteolytic activity, and the development of
ALA in an animal model of disease (12). Exposure to either
LY294002 (13) or wortmannin (14) inhibits pinocytosis of a flu-
orescent fluid-phase marker, fluorescein isothiocyanate (FITC)-
dextran, and disrupts phagocytosis (8, 10, 14) and adhesion to
host cells in a dose-dependent manner (8).
Several unique aspects of PI3K activity in E. histolytica make it
worthy of study. First, expression of PI3K is higher in virulent E.
histolytica than in nonvirulent E. dispar (15). Second, compared to
mammalian cells, E. histolytica has above average levels of
PI(3,4,5)P3 in the plasma membrane (10). Third, unlike in mam-
malian cells (16), serum withdrawal does not affect the steady-
state level of PI(3,4,5)P3 in E. histolytica (10). Fourth, the products
of PI3K, PI3P and PI(3,4,5)P3, localize to early-forming or newly
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sealed phagosomes (8–10). In contrast, localization of PI3P to
phagosomes in mammalian cells is observed only after their clo-
sure (17). Finally, although not much is known about encystation
in E. histolytica, wortmannin inhibits encystation in a related rep-
tilian pathogen, E. invadens (18). Therefore, it is possible that E.
histolytica encystation also requires PI3K activity. Thus, under-
standing the unique role of phosphoinositides and PI3K signaling
in E. histolytica may provide insight into infection.
In other systems, genomewide overexpression has been used to
identify targets of small-molecule drugs. For example, Butcher et
al. (19) used overexpression to identify genes regulating rapamy-
cin sensitivity and, hence, TOR kinase signaling. Similarly,
genomewide overexpression was used to define targets of a kinase
inhibitor, phenylaminopyrimidine (20), and two antifungal
drugs, tunicamycin and soraphen (21). Sequencing and annota-
tion of the E. histolytica genome (22, 23) have enabled the devel-
opment of whole-genome approaches to assign functions to
genes. However, to date, the only forward genetics approach that
has been applied to E. histolytica is a recent overexpression screen
that identified genes that negatively regulate phagocytosis (24).
In the current study, we have adapted an overexpression-based
chemical genomic approach (25) to uncover genes that may di-
rectly or indirectly participate in PI3K signaling. Specifically, we
applied a near-lethal dose of wortmannin to a population of cells
that had been transfected with an E. histolytica cDNA library to
select for cells that were less sensitive to the drug. We then identi-
fied the genes that were overexpressed in the survivors. The screen
was based on the hypothesis that cells in which wortmannin tox-
icity was genetically suppressed may be overexpressing genes that
directly or indirectly play a role in PI3K signaling.
MATERIALS AND METHODS
Strains and culture conditions. Entamoeba histolytica trophozoites
(strain HM-1:1MSS) were cultured axenically in TYI-S-33 medium (26)
in 15-ml glass screw-cap tubes at 37°C. The methods used to generate E.
histolytica cell lines that overexpress a GFP-tagged pleckstrin homology
(PH) domain from mammalian Bruton’s tyrosine kinase (GFP-PHBtk),
EhLimA, or luciferase (here referred to as Eh209) are described elsewhere
(10, 24, 27). The GFP-PHBtk and Eh209 transgenic cell lines were main-
tained in TYI-S-33 medium supplemented with 6 g/ml G418 and 15
g/ml hygromycin. Expression of GFP-PHBtk or luciferase was induced
by the addition of 5 g/ml tetracycline to the culture medium 24 h prior to
performing assays. The EhLimA-expressing cell line was maintained in a
medium supplemented with 23 g/ml hygromycin, and the drug concen-
tration was increased to 46 g/ml for 1 week prior to conducting experi-
ments.
The generation of a population of E. histolytica cells transfected with a
cDNA library in the E. histolytica expression vector pAH-DEST is de-
scribed elsewhere (24). Briefly, the cDNA library was constructed using
Invitrogen Custom Services (Invitrogen, Carlsbad, CA). RNA was isolated
from approximately 2.4  107 trophozoites using TRIzol reagent (Invit-
rogen) according to the manufacturer’s protocol. Poly(A) RNA was se-
lected from 2 mg total RNA and used to generate a primary, uncut, 7-fold
normalized cDNA library directionally cloned into the Gateway-compat-
ible entry vector pENTR222(f1). Proprietary 5= cap-binding technology
was used to select and enrich for full-length clones. The final titer of the
amplified library was 3.9  106 CFU/ml. Twenty-four random clones,
with a minimum of 20 different genes, were analyzed for the presence of
inserts. All 24 clones had inserts with an average size of 1.1 kb.
The LR Clonase system (Invitrogen) was used to transfer cDNA inserts
from pENTR222 to pAH-DEST (28), a Gateway-compatible E. histolytica
expression vector (kind gift from C. A. Gilchrist and W. A. Petri, Jr.,
Department of Medicine, Division of Infectious Diseases and Interna-
tional Health, University of Virginia, Charlottesville, VA). This plasmid is
episomal in nature and confers hygromycin resistance to transfectants.
Expression from this plasmid is driven by upstream ferredoxin regulatory
sequences. The cDNA library in pAH-DEST was transfected into HM1:
IMSS trophozoites using standard protocols (10, 29). Transfectants were
maintained by the addition of 23 g/ml hygromycin to the medium.
E. histolytica trophozoites were transfected with expression plasmids
encoding SREHP or EhCoactosin using standard transfection protocols
(10, 29). These 2nd-generation SREHP and EhCoactosin overexpressors
were maintained in a medium supplemented with 23 g/ml hygromycin,
and the drug concentration was increased to 46 g/ml for 1 week prior to
conducting experiments.
Measurement of wortmannin toxicity and chemical genomics
screen. Log-phase trophozoites (6  104 cells) were seeded into 39 ml of
TYI-S-33 medium containing a range of concentrations of wortmannin or
its diluent, dimethyl sulfoxide (DMSO), and grown for 3 days in 15-ml
glass screw-cap tubes at 37°C. Fresh TYI-S-33 medium containing the
drug or the diluent was supplied to the cells every 24 h over the course of
treatment. Cell viability was measured by microscopy with Trypan blue
exclusion. A near-lethal concentration of wortmannin (2 mM) was ap-
plied to the library of overexpressing trophozoites for 3 days with a me-
dium change every 24 h.
Isolation of episomes from survivors and sequencing. Total DNA
was isolated from the population of cells that survived wortmannin selec-
tion or from the parental population of cells not exposed to wortmannin
(control) using the Wizard genomic DNA purification kit (Promega,
Madison, WI). The isolated DNA was transformed into Escherichia coli
(XL10 Gold; Stratagene, La Jolla, CA) by standard transformation proto-
cols. The resulting ampicillin-resistant bacterial colonies were randomly
chosen from each condition (unselected control or wortmannin selec-
tion), transferred to the wells of 96-well plates containing LB medium
supplemented with ampicillin (100 g/ml) and glycerol (50%, vol/vol),
and stored at 80°C. Frozen samples were transferred to the Arizona State
University BioDesign Institute (Tempe, AZ) for automated plasmid iso-
lation and sequencing.
Analysis of expression by quantitative real-time PCR (RT-qPCR).
Cell lines were grown to mid-log phase (3  105 cells/ml). Total RNA was
isolated from these cell lines with TRIzol reagent (Invitrogen, Carlsbad,
CA), and 2 g of RNA was treated with DNase I for 30 min at 37°C. The
cDNAs were synthesized with oligo(dT) and Superscript III reverse trans-
criptase (Invitrogen) at 50°C for 2 h.
Expression of SREHP or EhCoactosin transcripts was measured by RT-
qPCR using the RT2 SYBR green fluor qPCR mastermix (SABiosciences,
Frederick, MD) and the appropriate primers for SREHP (forward primer,
5=-GCTGCATCAAGTCCATTCATTG-3=; reverse primer, 5=-GATAGAA
ATATTTATCCCAACTAAAGAC-3=) and EhCoactosin (forward primer,
5=-TTAGTGAAGTTGCTGGCCCAGTTG-3=; reverse primer, 5=-GCAT
CTTCCTTAAGGGCAGCTTTG-3=). Normalization of the levels of
cDNA was carried out by comparing expression to that of a housekeep-
ing gene, the small subunit rRNA (ssRNA) (accession no. X61116) (30)
(forward primer, 5=-AGGCGCGTAAATTACCCACTTTCG-3=; reverse
primer, 5=-CACCAGACTTGCCCTCCAATTGAT-3=). Normalization
ratios were calculated using the Pfaffl method (31). At least two indepen-
dent biological replicates were evaluated. For each cDNA, three technical
replicates were performed and the values averaged. The efficiency of each
primer pair was assessed by use of a dilution series. In all cases, efficiency
values were 88% and R2 values were 0.935.
LY294002 and cycloheximide sensitivity assays. To test for LY294002
sensitivity, log-phase trophozoites (2  104 cells) were seeded into 13 ml of
TYI-S-33 medium containing 50 or 25 M LY294002 or an equivalent
volume of DMSO (diluent control) and grown for 3 days in 15-ml glass
screw-cap tubes at 37°C. Fresh TYI-S-33 medium containing the drug or
the diluent was supplied to the cells every 24 h over the course of treat-
ment. Cell viability was measured by microscopy with Trypan blue exclu-
sion.
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The cycloheximide sensitivity assay was employed as described previ-
ously (24). Briefly, trophozoites (3  104 cells) were seeded into 13 ml of
TYI-S-33 medium supplemented with 100 nM cycloheximide or an
equivalent volume of PBS (diluent control) and incubated at 37°C for 48
h. Cell viability was assessed by microscopy with Trypan blue exclusion.
Whole-cell lipid extraction and PI(3,4,5)P3 dot blots. Total lipid was
extracted from trophozoites according to the methods of Gray et al. (32).
Briefly, 1  106 cells were washed twice with phosphate-buffered saline
(PBS). Lipids were precipitated with 5 ml of 0.5 M trichloroacetic acid
(TCA) and centrifuged at 500  g for 5 min at 4°C. The pellets were
washed with 3 ml of 5% (wt/vol) TCA–1 mM EDTA and centrifuged at
500  g for 5 min. To facilitate neutral lipid extraction, 3 ml of methanol-
chloroform (2:1) was added to the pellets, and the mixture was vortexed 3
times over a period of 10 min at room temperature. The extracted lipids
were centrifuged at 500  g for 5 min at 4°C. To facilitate acidic lipid
extraction, 2.25 ml methanol-chloroform-12.1N HCl (80:40:1) was
added, and the mixture was vortexed 4 times during 15 min at room
temperature and centrifuged at 500  g. The resulting supernatant was
subjected to a phase split by the addition of 750 l chloroform and 1.35 ml
0.1N HCl. The solution was centrifuged at 500  g for 5 min at 4°C. After
centrifugation, the organic phase was collected and vacuum dried, and the
pellets were used for lipid dot blot analysis.
Lipids were spotted onto Hybond-C nitrocellulose membrane. The
membrane was blocked in 1.5% (wt/vol) fatty acid-free bovine serum
albumin (BSA) at room temperature for 1 h and probed with mouse
anti-PI(3,4,5)P3 antibody (1:1,000 dilution) (Echelon Biosciences, Salt
Lake City, UT) followed by incubation with secondary antibody, i.e., per-
oxidase-conjugated goat anti-mouse IgG (1:2,000 dilution) (Cappel; ICN
Pharmaceuticals, Costa Mesa, CA). Immunoblots were visualized using
the enhanced chemiluminescence Western blotting detection system
(Pierce Biotechnology, Rockford, IL) according to the manufacturer’s in-
structions. Semiquantitative densitometric analyses of immunoblots were
performed using ImageJ software (version 1.42q; U.S. National Institutes
of Health, Bethesda, MD).
Measurement of motility. Motility assays were carried out according
to the methods of Zaki et al. (33). Briefly, 8 ml of complete TYI-S-33
medium, supplemented with 0.75% (wt/vol) agarose, was poured into
60-mm petri dishes and allowed to solidify at room temperature. A trough
(2 by 30 mm) was cut into the solidified medium to serve as the motility
chamber. Trophozoites were incubated in serum-free media for 1 h at
37°C. Following this incubation, 5  105 cells were placed in the trough of
the motility chamber. A coverslip (22 by 40 mm) was placed over the
trough, and the plate was incubated at 37°C for 3 h in 5% CO2. After 3 h,
images were captured using an LSM510 confocal microscope (Carl Zeiss
MicroImaging, Thornwood, NY). For each trial, at least 3 measurements
of the distance between the trough and the leading edge of the population
of cells were taken using Zeiss LSM510 image analysis software.
Statistical analyses. All values are given as means  standard devia-
tions (SD) from at least 3 trials. To compare means, statistical analyses
were performed using GraphPad Instat V.3 with a one-way analysis of
variance (ANOVA) and a Tukey-Kramer multiple-comparison test. To
compare the composition of the gene set obtained before and after selec-
tion, we used a statistical Z-test. In all cases, P values less than 0.001 (***)
were considered highly statistically significant, while P values less than
0.01 (**) or 0.05 (*) were considered statistically significant.
In silico analyses. Structural and functional amino acid residues and
domains in the EhCoactosin protein were identified using ExPASy
ScanProsite (34). Cartoon renderings of the EhCoactosin protein were
generated using the MyDomains-Image Creator in ExPASy PROSITE.
The Clustal W algorithm was used for comparison of coactosin protein
sequences (MacVector 9.0; MacVector, Cary, NC).
RESULTS
Development of chemical genomic screen to enrich for mutants
hyposensitive to wortmannin. Wortmannin is a cell-permeant,
small-molecule metabolite isolated from the fungus Talaromyces
wortmanni (35). In mammalian cells, wortmannin can irrevers-
ibly inhibit PI3K at low nanomolar concentrations (7). To evalu-
ate wortmannin toxicity in E. histolytica, we exposed trophozoites
to a range of concentrations of wortmannin over 3 days. In E.
histolytica, PI3P and PI(3,4,5)P3 staining were eliminated by 60
nM (8) and 500 nM (10) wortmannin, respectively. Since we were
interested in completely disabling PI3K, we tested a range of con-
centrations from 500 nM (data not shown) to 4 mM wortmannin.
To ensure the presence of active inhibitor, the spent medium was
exchanged with fresh wortmannin-containing medium daily. The
viability of the trophozoites was assessed and reported as a per-
centage of untreated control cells. Near 100% death of the tropho-
zoite population was achieved with 2 mM (1.5% viable after 3
days), 3 mM (0.9% viable after 3 days), and 4 mM (0.5%
viable after 3 days) wortmannin (Fig. 1). Furthermore, there was
no statistically significant difference when 2 mM wortmannin tox-
icity was compared to that of higher doses. Cell viability was not
significantly affected by the diluent, DMSO (Fig. 1). This suggests
that cell death was specific to the presence of wortmannin. To
minimize off-target effects of wortmannin and to maximize the
chances of identifying genes authentically connected to PI3K sig-
naling, 2 mM wortmannin treatment was chosen for the chemical
genomics screen.
Screening with wortmannin identifies genes that may func-
tion in PI3K signaling. E. histolytica cells were transfected with a
cDNA overexpression library constructed in the episomal, consti-
tutive expression vector pAH-DEST (28) as described previously
(24). The transgenic population of cells was exposed to 2 mM
wortmannin over a 3-day period. The surviving cells were allowed
to recover for a 48-h period. Episomes from the surviving popu-
lation were purified and amplified in E. coli. The cDNAs were
identified by sequencing. As a control, episomes were also isolated
and sequenced from the transgenic population of cells that was
not subjected to this selection. Table 1 shows the identity and
frequency of cDNAs isolated from trophozoites that survived se-
lection compared to those recovered randomly from a population
of overexpressing cells not subjected to selection. To determine if
the set of genes enriched after selection was significantly different
FIG 1 Wortmannin is toxic to E. histolytica. Trophozoites (2  104 cells) were
exposed to a range of concentrations of wortmannin or its diluent, dimethyl
sulfoxide (DMSO), or an equivalent volume of media (control) and grown for
3 days. Cell viability was assessed and expressed as a percentage of untreated
control cells. The data represent the means  SD from 3 trials (***, P  0.001).
Treatment with 2 mM or higher concentrations of wortmannin resulted in the
death of nearly 100% of the cells.
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from that in the control population, we used a statistical Z-test.
The statistical difference between genes isolated by selection and
those isolated randomly from a control population approached
significance (P 	 0.05262). This analysis suggests a nonfortuitous
enrichment of specific genes by wortmannin treatment.
The cDNA encoding an actin-binding protein with an actin
depolymerization factor homology (ADF-H) domain (EhCoactosin;
XM_645834.2) was the most highly enriched of the cDNAs. It was
present in 14.4% of the bacterial clones that had been transformed
with episomes isolated from trophozoite survivors. The corre-
sponding protein is predicted to be 148 amino acid long (16.2
kDa) and was previously identified in a proteomic analysis of pu-
rified phagosomes from E. histolytica (36). Like other coactosins,
EhCoactosin belongs to the ADF/cofilin family of proteins and
contains a putative F-actin binding domain. It is also predicted to
possess a putative myristoylation, several casein kinase II sites, and
protein kinase C phosphorylation sites (Fig. 2A). These phosphor-
ylation sites indicate a possible role for coactosin in cell signaling
in E. histolytica. Cofilin, one of the founding members of the ADF/
cofilin family, has been shown to be a downstream effector of PI3K
activity (37). However, to our knowledge, this is the first study to
reveal a functional connection between a coactosin-like protein
and PI3K in any system.
A sequence alignment revealed that EhCoactosin shares high
homology with coactosins from other systems (Fig. 2B). Impor-
tantly, Lys75 of human coactosin, which is required for interaction
with F-actin, is conserved in EhCoactosin, suggesting that the E.
histolytica protein is an authentic actin-binding protein. The
129LKKAGG134 sequence motif, specifically Lys131, on the C-ter-
minal end of human coactosin is necessary for interaction with
5-lipoxygenase (5-LO), an enzyme that is involved in leukotriene
biosynthesis (38). Although E. histolytica does not appear to pos-
sess 5-LO-like proteins, EhCoactosin harbors a similar motif at its
C terminus which may facilitate its interaction with other pro-
teins.
The cDNA encoding the serine-rich E. histolytica protein
(SREHP; M80910.0) was present in 4.4% of the bacterial clones
that had been transfected with the episomes isolated from tropho-
zoite survivors. It is proposed to be a cell surface receptor that
facilitates host-parasite or parasite-parasite interaction through
chemoattraction (39). Its potential as a vaccine target has been
established (40). SREHP is a cell surface protein, a potential che-
moattractant, and is itself phosphorylated. These are all hallmarks
of signaling proteins. Thus, it was intriguing to isolate it in a screen
for protein partners of PI3K signaling.
The cDNA encoding a Ras family GTPase (EhRap2;
XM_646071.2) was isolated from 8.9% of bacterial clones that
had been transfected with episomes from trophozoite survivors.
Rap GTPases are known to participate in PI3K signaling in other
systems (41, 42), supporting the validity of our screen. Because of
its known connection to PI3K signaling, we did not conduct ad-
ditional studies with EhRap2. The cDNA encoding the 40S ribo-
somal protein S14 (XM_648457.2), the 60S ribosomal protein L10
(XM_647007.2), and the ehapt2 retrotransposable element
(AY141199.1) were isolated from 10%, 7.8%, and 13.3%, respec-
tively, of bacterial clones that had been transfected with episomes
from trophozoite survivors. These genes also were not chosen for
further study, because overexpression of ribosomal proteins or
retrotransposons may have profound nonspecific effects on pro-
tein synthesis and gene expression. Furthermore, several of the
cDNAs encoding ribosomal proteins also were identified in the
unselected control population (Table 1).
Authentication of EhCoactosin and SREHP. EhCoactosin
was selected for additional analysis, because it was the most abun-
dant cDNA isolated in the screen and because it may be the first
coactosin-like protein to exhibit a functional connection to PI3K.
SREHP was selected because of its potential as a signaling mole-
cule and its importance as a vaccine target. Expression vectors
encoding EhCoactosin and SREHP, isolated in the original screen,
were transfected into wild-type trophozoites to construct 2nd-
generation cell populations overexpressing these proteins. Over-
expression of SREHP and EhCoactosin transcripts was confirmed
by RT-qPCR (Fig. 3A and B). SREHP and EhCoactosin transcripts
exhibited 3.6- and 7.1-fold higher abundance, respectively, in the
2nd-generation transgenic cell lines than in the parental controls
(Fig. 3A and B).
To validate the isolation of EhCoactosin and SREHP in the
screen, we exposed the 2nd-generation transgenic cell lines to se-
lection with 1 mM and 2 mM wortmannin for 3 days and reas-
sessed toxicity. These cell lines exhibited significantly higher sur-
vival after exposure to wortmannin than control diluent-treated
cells (Fig. 4A). To test if the decreased susceptibility to the drug
was due simply to the presence of episomal DNA, we tested wort-
TABLE 1 Isolation of cDNAs from E. histolytica overexpressers with and
without selection with 2 mM wortmannin
GI no. Gene name
No. of isolatesa
Control Selected
XM_645834.2 Actin binding protein, EhCoactosin 2 13
AY141199.1 Ehapt2 retrotransposon 1 12
XM_648457.2 40S ribosomal protein S14, putative 4 9
XM_646071.2 Ras family GTPase, EhRap2 1 8
XM_647007.2 60S ribosomal protein L10, putative 1 7
XM_645248.2 60S ribosomal protein L7, putative 5 7
XM_647452.2 60S ribosomal protein L17, putative 3 5
M80910.1 SREHP 1 4
XM_650080.1 Alcohol dehydrogenase, putative 7 3
XM_650825.1 40S ribosomal protein S25, putative 4 3
XM_644144.2 Hypothetical protein, H644 6 2
AY141200.1 Ehapt2 retrotransposon 2 2
XM_646441.2 40S ribosomal protein S12, putative 0 2
XM_652064.2 40S ribosomal protein S7, putative 0 1
XM_647340.1 60S ribosomal protein L7a, putative 0 1
X90911.1 Profilin 0 1
XM_651795.2 60S ribosomal protein L7, putative 0 1
XM_650280.2 Hypothetical protein, BAR and SH3
domain-containing protein
0 1
XM_644485.1 40S ribosomal protein S25, putative 1 1
XM_651024.2 60S ribosomal protein L4, putative 1 1
XM_645170.2 Serine protease inhibitor, putative 2 1
XM_644082.2 60S ribosomal protein L14, putative 2 1
XM_645695.2 60S ribosomal protein L13, putative 4 1
XM_644069.2 Enolase, putative 4 1
XM_643252.2 60S ribosomal protein L15, putative 5 1
XM_647370.2 60S ribosomal protein L9 6 1
Z48752.1 Alcohol dehydrogenase 3 6 0
XM_645775.2 Hypothetical protein 9 0
XM_646205.2 60S ribosomal protein L23, putative 1 0
XM_651193.2 40S ribosomal protein S9, putative 1 0
XM_650207.2 C2 domain containing protein 3 0
XM_651611.2 Vacuolar ATP synthase subunit E, putative 1 0
XM_643162.2 Serine-rich protein 1 0
XM_651764.2 60S ribosomal protein L11, putative 1 0
XM_648038.2 Hypothetical protein, mRNA 1 0
XM_001913740.1 40S ribosomal protein S7, putative 1 0
XM_645636.1 Rho GTPase activating protein, putative 1 0
XM_652029.2 Hypothetical protein 1 0
Total 89 90
a E. histolytica overexpressors were left untreated (control) or were subjected to
selection with 2 mM wortmannin (selected).
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mannin toxicity in another cell line overexpressing an irrelevant
protein, EhLimA, from the same nonintegrating expression vector
(24). There was no significant increase in the number of survivors
after wortmannin treatment in the EhLimA-expressing popula-
tion (Fig. 4A). This suggests that the genetic suppression of wort-
mannin toxicity by EhCoactosin or SREHP overexpression is gen-
uine.
If overexpression of EhCoactosin or SREHP authentically res-
cues E. histolytica cells from wortmannin toxicity, it is conceivable
that overexpression should also confer resistance to other PI3K
inhibitors. To test this, we quantified viability in the 2nd-genera-
tion cell lines exposed to 50 M LY294002, a concentration
known to strongly inhibit staining with a PI3P biosensor in E.
histolytica (8). Cells overexpressing SREHP exhibited reduced
sensitivity to LY294002 toxicity (Fig. 4B), supporting a functional
connection between SREHP and PI3K signaling. However, over-
expression of EhCoactosin did not protect cells from exposure to
LY204002 at this concentration. One possibility was that our test
with LY294002 was too stringent. Therefore, we assessed the via-
bility of the EhCoactosin-expressing cell line after exposure to a
lower concentration (25 M) of LY294002. In this case, we ob-
served increased survival of the EhCoactosin-expressing cell line
(Fig. 4C) compared to diluent-treated control cells. This corrob-
orates the isolation of EhCoactosin in the original screen and in-
dicates that expression of SREHP is more efficient at protecting
cells from LY294002 toxicity than expression of EhCoactosin.
EhCoactosin or SREHP could represent false positives if their
overexpression leads to a nonspecific multidrug-resistant pheno-
type. To address this possibility, we examined the specificity of the
response by testing the susceptibility of EhCoactosin- and
SREHP-overexpressing cells to an unrelated small molecule, cy-
cloheximide, as previously described (24). There was no signifi-
cant difference in survival of the 2nd-generation transgenic and
parental control cell lines (Fig. 5). This indicated that the isolation
of EhCoactosin and SREHP from our original screen was not due
to a multidrug resistance phenotype characterized by nonspecific
extrusion of small molecules.
Although SREHP has been characterized (39, 40, 43, 44), little
FIG 2 Domains found in EhCoactosin and sequence comparison of coactosin from E. histolytica to those of other species. (A) EhCoactosin is an F-actin binding
protein with a postulated molecular mass of 16.2 kDa (148 amino acids). It is predicted to have an actin depolymerization factor homology (ADF-H) domain
(orange hexagon), an N-myristoylation site (gray vertical line labeled M), 4 casein kinase II phosphorylation sites (red flags labeled C), and a protein kinase C
phosphorylation site (red flag labeled P). (B) The predicted amino acid sequence of EhCoactosin was aligned with coactosin from other organisms using
ClustalW multiple sequence alignment, v1.4 (MacVector v9.0). Conserved amino acids are shaded, and the consensus sequence is indicated below the aligned
sequence (#, conservation but no consensus). The E. histolytica ADF-H domain is indicated by the red line. Asterisks represent the lysine residues Lys75 and Lys131
of human coactosin that are essential for binding to F-actin and 5-lipoxygenase, respectively.
FIG 3 RT-qPCR confirms overexpression of EhCoactosin and SREHP. RNA
from untransfected (wild type; WT) log-phase E. histolytica trophozoites or
from trophozoites transfected with an expression vector encoding SREHP or
EhCoactosin was used for RT-qPCR analysis of expression. The ssRNA gene
was used as a loading control. SREHP and EhCoactosin were expressed at
approximately 3.6 (0.5)-fold and 7.1 (1.8)-fold, respectively, above wild-
type levels. The data represent the means  SD from 2 biological replicates and
3 technical replicates per biological replicate (**, P  0.01; ***, P  0.001).
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is known about EhCoactosin, except that it is associated with E.
histolytica phagosomes (36). In other systems, increased expres-
sion of coactosin correlates with enhanced cell motility (45, 46).
Therefore, to verify EhCoactosin as an authentic coactosin family
member, we performed a previously published under-agar motil-
ity assay (47) on the 2nd-generation EhCoactosin overexpressors.
EhCoactosin-overexpressing cells traveled a significantly longer
distance in a 3-h time frame than untransfected control tropho-
zoites (Fig. 6), suggesting that this protein, like other coactosins,
has a cell migration function in E. histolytica.
Alteration in the level of phosphatidylinositol (3,4,5)-
triphosphate affects expression of EhCoactosin and SREHP. We
used an independent genetic test to affirm the connections be-
tween PI3K and EhCoactosin or SREHP. Previously, it was re-
ported that a transgenic cell line overexpressing a GFP-tagged
pleckstrin homology (PH) domain, from mammalian Bruton’s
tyrosine kinase (GFP-PHBtk), exhibited reduced phagocytosis
(10), increased motility (10), and decreased levels of PI(4,5)P2
(48). Since the levels of PI(4,5)P2 and PI(3,4,5)P3 are tightly coor-
dinated, we predicted that PI(3,4,5)P3 abundance also was altered
in this cell line. Thus, we measured the level of PI(3,4,5)P3 using a
lipid dot blot analysis of whole-cell extracts from untransfected
parent cells and the GFP-PHBtk cell line. Compared to untrans-
fected trophozoites, GFP-PHBtk-expressing cells exhibited a 2.6-
fold increase in PI(3,4,5)P3 (Fig. 7A and B). To determine if the
increase in PI(3,4,5)P3 was due to the presence of episomal expres-
sion plasmids, we also measured PI(3,4,5)P3 in a control cell line
(Eh209) expressing an irrelevant protein, luciferase, from the
FIG 4 SREHP and EhCoactosin overexpressors are less susceptible to wortmannin and LY294002 toxicity. Transgenic trophozoites were exposed to 1 mM or 2
mM wortmannin (A), 50 M LY294002 (B), or 25 M LY294002 (C) for 3 days, after which viability was assessed. The data are reported as a percentage of
diluent-treated control amoebae and represent the means  SD from 3 trials (*, P  0.05). (A) SREHP- and EhCoactosin-overexpressing cells exhibited increased
survival in the presence of wortmannin compared to untransfected wild-type (WT) cells or another transgenic cell line overexpressing an irrelevant gene,
EhLimA, from the same expression vector. (B) SREHP-overexpressing cells exhibited enhanced survival in the presence of 50 M LY294002. (C) EhCoactosin-
overexpressing cells exhibited enhanced survival in the presence of 25 M LY204002.
FIG 5 Cycloheximide is toxic to E. histolytica cells overexpressing SREHP and
EhCoactosin. Transgenic trophozoites were exposed to 100 nM cycloheximide
for 48 h, and viability was assessed. The data are presented as a percentage of
untreated control cells and represent the means  SD from 3 trials. Cyclohex-
imide was toxic to both wild-type (WT) and transgenic amoebae. Therefore,
cells overexpressing SREHP and EhCoactosin may not have a multidrug resis-
tance phenotype.
FIG 6 Cells overexpressing EhCoactosin display increased cell motility. A
motility assay was performed on EhCoactosin overexpressors or untransfected
wild-type (WT) cells. Images of cells moving under agar were captured using
confocal microscopy. The maximum distance migrated by lead trophozoites
was measured. The data represent the means  SD from 3 trials (***, P 
0.001).
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same pGIR209 (27) expression vector. The level of PI(3,4,5)P3 was
not significantly higher in the control transgenic cell line, suggest-
ing that the quantity of this signaling lipid is authentically higher
in GFP-PHBtk-expressing cells. Given that PI(3,4,5)P3 is the prod-
uct of PI3K, increased levels of this lipid may be the genetic equiv-
alent of enhanced PI3K activity.
Products of PI3K may propagate a signal by interacting with
and phosphorylating downstream effector proteins (reviewed in
reference 7). One outcome of signaling is changes in gene expres-
sion (49–51). Therefore, we measured the level of EhCoactosin
and SREHP transcript in the GFP-PHBtk cell line to assess the
impact of altered levels of PI(4,5)P2 (48) and PI(3,4,5)P3 (this
study). Compared to wild-type cells, there was a 1.65-fold increase
in the abundance of SREHP transcript (Fig. 8A) and a 3.4-fold
increase in the abundance of EhCoactosin transcript (Fig. 8B) in
cells expressing GFP-PHBtk. SREHP and EhCoactosin transcript
levels were not significantly higher in a control transgenic cell line
expressing an irrelevant protein, luciferase (Eh209) (Fig. 8A and
B). This indicated that the increase in SREHP and EhCoactosin
transcripts in the GFP-PHBtk-expressing cells was not due to the
presence of episomal DNA or the application of selection. These
expression data support the connection between PI3K signaling
and EhCoactosin and SREHP.
DISCUSSION
In this study, we utilized a functional genomics approach to iden-
tify genes that may directly or indirectly function in the PI3K
pathway in E. histolytica. We uncovered at least one gene, a Rap
GTPase, that participates in PI3K signaling in other systems. Our
study also identified several genes not previously identified as
partners in PI3K signaling, including SREHP and a coactosin-like
protein, EhCoactosin. A mutant cell line with an increased level of
PI(3,4,5)P3, the product of PI3K activity, exhibited increased ex-
pression of SREHP and EhCoactosin. This supports the functional
connection between these proteins and PI3K in E. histolytica. The
assignment of SREHP and EhCoactosin as partners operating with
PI3K signaling is novel.
Although not examined in detail, the enrichment of the
EhRap2-coding gene in our screen was intriguing. E. histolytica
possesses two Rap isoforms, EhRap1 and EhRap2, which share
over 91% identity (52). EhRap2 shares at least 60% identity with
Rap1 proteins from other systems and at least 50% identity with
Rap2 proteins from other systems. Like other Rap1 proteins (41,
53), EhRap2 localizes to phagosomes (54). In platelets, PI3K can
activate Rap1 (54, 55). In Dictyostelium discoideum, Rap1 interacts
with the Ras-binding domain of PI3K to modulate cell polarity
and pseudopod formation (42). EhRap2 possesses all of the effec-
tor binding domains and switch I and switch II regions (data not
shown) that are necessary for interaction with PI3K (reviewed in
references 56 and 57). Since, in E. histolytica, EhRap2 (54), PI3K
(36), and the products of PI3K (8–10) localize to phagosomes, and
since EhRap2 was highly enriched among the wortmannin-se-
FIG 7 GFP-PHBtk overexpressors display altered PI(3,4,5)P3 levels. Phosphoi-
nositides were extracted from whole-cell lysates, and PI(3,4,5)P3 levels were
measured using dot blots with antibodies specific to PI(3,4,5)P3. (A) A typical
dot blot is shown. (B) Blot densities were analyzed by ImageJ software (version
1.42q). The density for the untransfected wild type (WT) was arbitrarily set to
1, and all other data are reported as a ratio to the WT. The data represent the
means  SD from 3 trials. PI(3,4,5)P3 levels were higher in GFP-PH
Btk-ex-
pressing cells (*, P  0.05) than in WT cells or in a control cell line expressing
an irrelevant protein, luciferase (Eh209).
FIG 8 GFP-PHBtk overexpressors possess increased levels of EhCoactosin and
SREHP transcripts. RNA from untransfected (wild type; WT) log-phase E.
histolytica trophozoites, from a cell line expressing a GFP-tagged PH domain
(GFP-PHBtk), and from a cell line expressing an irrelevant protein, luciferase
(Eh209), was used for qPCR analysis of expression. The ssRNA gene was used
as a loading control. (A) SREHP was expressed in the GFP-PHBtk cell line at a
level that was approximately 1.65 (0.07)-fold (**, P  0.01) higher than that
in WT cells. (B) EhCoactosin was expressed in the GFP-PHBtk cell line at a level
that was approximately 3.4 (0.57)-fold (***, P  0.001) higher than that in
WT levels cells. Neither SREHP nor EhCoactosin was expressed at a higher
level in the control cell line (Eh209), suggesting that the increase seen in the
GFP-PHBtk cell line was authentic. The data represent the means  SD from
3 biological replicates.
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lected population (this study), it is reasonable to hypothesize that
similar local EhRap2/PI3K associations exist.
In our study, the cDNA encoding ehapt2 was also highly en-
riched in the wortmannin-selected population. The genome of E.
histolytica contains non-long terminal repeat (non-LTR) retro-
transposons (58, 59). These include the long interspersed repeti-
tive elements (LINEs) and the short interspersed repetitive ele-
ments (SINEs). Ehapt2 is a member of the EhSINE1 family
of retrotransposable elements. Ehapt2 is present in the vicinity of
protein-coding genes (60) and may influence the expression of
such genes. Although Yadav et al. (61) reported that laboratory
strains of E. histolytica may be retrotransposition incompatible,
discerning the genomic position of ehapt2 in trophozoites that are
less sensitive to wortmannin is necessary to fully understand the
connection, if any, to PI3K signaling.
Several hypothetical protein-coding genes were also isolated in
our screen. One such protein, H644 (XM_644144.2), was previ-
ously identified in a screen for negative regulators of phagocytosis
(24). Overexpression of H644 strongly reduced phagocytosis of
human red blood cells by E. histolytica (24). A second hypothetical
protein (XM_650280.2) contained an N-terminal Bin-Am-
phiphysin-Rvs (BAR) superfamily domain and a C-terminal SH3
domain. BAR domain proteins are evolutionarily conserved and
bind to the plasma membrane. Specifically, BAR domains induce,
stabilize, or detect membrane curvatures and facilitate the inter-
action between the plasma membrane and the underlying cyto-
skeleton (62). Interestingly, H644 possesses a significant number
of putative phosphorylation sites (24), and many BAR domain-
containing proteins possess SH3 domains (63, 64). Thus, these
hypothetical proteins may be authentic signaling molecules, and
their identification in our screen may not be fortuitous.
Several ribosomal protein-coding genes were highly enriched
in our screen. These may or may not be authentic participants in
PI3K signaling. In a screen of yeast deletion mutants for wortman-
nin sensitivity, 119 of the 1,067 genes, including several ribosomal
protein-coding genes, were functionally characterized to be in-
volved in protein synthesis (25). Therefore, it is possible that in
our study, overexpression of ribosomal proteins has a direct or
indirect connection to PI3K-based signaling.
The most highly enriched cDNA in our screen was EhCoactosin.
Coactosin, an F-actin binding protein, was first isolated from the
actin-myosin complex of Dictyostelium discoideum (45). Subse-
quently, coactosin-like proteins (CLPs) have been identified in
other systems (46, 65, 66). Coactosin contains an actin depo-
lymerizing factor homology (ADF-H) domain, a structurally con-
served motif that allows proteins to interact with actin and to
remodel the actin cytoskeleton (reviewed in reference 67). In gen-
eral, coactosins only bind F-actin (46, 65, 68). With the exception
of D. discoideum coactosin, which weakly interferes with barbed-
end capping of actin filaments (68), coactosins do not seem to
promote actin filament elongation or disassembly. It has been
suggested that, in vivo, coactosins regulate actin dynamics as a
member of a complex with other proteins (69). EhCoactosin pos-
sesses an ADF-H domain; however, it remains to be seen if it binds
actin and if it has additional interacting protein partners.
Coactosin has been implicated in cell motility. In D. discoi-
deum, coactosin is concentrated in pseudopods (45). In develop-
ing chick embryos, coactosin is expressed in migrating neural crest
cells (46). Additionally, the levels of coactosin mRNA are higher in
motile and migrating cells. For example, in D. discoideum, coac-
tosin mRNA reaches a peak level in aggregating cells that are re-
sponding chemotactically to cyclic AMP (45). There is also evi-
dence for local translation of coactosin mRNAs at cellular
extensions in oculomotor nerves (46) and in the pseudopods of
human metastatic tumor cells (70). We showed that the level of
EhCoactosin transcript is higher in the GFP-PHBtk overexpres-
sors. Interestingly, this cell line also exhibits increased motility
(10). Furthermore, we demonstrated that overexpression of
EhCoactosin is sufficient to increase motility. Together, these data
suggest that EhCoactosin is an authentic member of the coactosin
family.
Coactosin may also play a role in phagocytosis in lower eu-
karyotes, as evidenced by its identification in the proteome of
purified phagosomes of D. discoideum (71, 72) and E. histolytica
(36). PI3K itself also localizes to E. histolytica phagosomes (36).
The mechanism by which increased levels of PI(3,4,5)P3 lead to
increased expression of EhCoactosin has not been discerned.
However, given that both proteins localize to the same organelle,
and given that EhCoactosin has several phosphorylation sites, it is
possible that, in addition to regulating expression of EhCoactosin,
PI3K also regulates activity of EhCoactosin by phosphorylation. It
remains to be seen if EhCoactosin physically interacts with PI3K
or its products.
SREHP has also been implicated in E. histolytica phagocytosis.
In particular, trophozoites can induce host cell apoptosis via
caspase-3 activation (73). This is followed by preferential phago-
cytosis of apoptotic cells over healthy cells (73). SREHP is thought
to be a cell surface receptor facilitating the binding and uptake of
apoptotic host cells (44). SREHP also undergoes posttranslational
modifications, including phosphorylation, O-linked terminal N-
acetylation, and acylation (39). Given its subcellular localization,
posttranslational modifications, and function as a receptor for
apoptotic cells, it has been hypothesized to be involved in cell
signaling (44). In the current study, identification of SREHP sup-
ports its role in signal transduction, perhaps through a PI3K-me-
diated pathway.
Recently, we discovered that SREHP localizes to lipid rafts in E.
histolytica (data not shown). Lipid rafts are small cholesterol- and
sphingolipid-rich membrane domains that regulate signaling, in-
cluding PI3K signaling. In E. histolytica the PI3K substrate,
PI(4,5)P2, is also enriched in rafts (47). Although it remains to be
seen if PI(3,4,5)P3 is localized to rafts in E. histolytica, the connec-
tion between SREHP and PI3K is strengthened by the fact that
SREHP colocalizes with PI3K-based signaling lipids in rafts.
It is conceivable that overexpression of PI3K itself would
have protected the cells from near-lethal doses of a PI3K inhib-
itor. However, we did not identify cDNAs encoding PI3Ks.
There are several possible explanations for our inability to iso-
late PI3K-encoding genes in this screen. First, the screen was
not exhaustive. The cDNAs from only 96 E. coli transformants
were sequenced. Therefore, it is possible that additional sequenc-
ing will identify cDNAs encoding E. histolytica PI3Ks. The E. his-
tolytica genome possesses at least 8 putative PI3Ks (data not
shown), but it remains to be seen which of these are authentic
PI3Ks. Second, the screen may have been too stringent. Although
the false-positive discovery rate would have increased, screening
with lower concentrations of wortmannin may have revealed
genes encoding authentic PI3Ks.
This study enhances our knowledge of PI3K signaling in E.
histolytica, which, in turn, provides insight into virulence. This
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study also illustrates the utility of full-genome functional genetic
screens in this parasite. Our screen was based on a simple pheno-
type, cell viability. Predictably, future forward and reverse genetic
screens, based on more complex phenotypes, are likely to lead to
the functional annotation of many genes in this organism. This
will, undoubtedly, reveal new targets for the development of vac-
cines or therapies against E. histolytica infection.
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